India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.

Robert F. Kennedy Jr, a vaccine critic who has pledged to tackle chronic disease, was named U.S. Health Secretary on Thursday ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Arizona Attorney General Kris Mayes on Thursday sued pharmaceutical manufacturer GlaxoSmithKline for engaging in deceptive and unfair practices ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

Alliance Pharma said that expected revenue fell, dragged down by consumer healthcare, and stuck to its guidance for the year. The medicine and healthcare-product supplier said Friday that expected ...

1 Day PBH -2.10% DJIA -0.75% S&P Mid Cap 400 -0.90% Health Care/Life Sciences 0.29% ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

Copyright 2025 The Associated Press. All Rights Reserved. Consumer Financial Protection Bureau Director Rohit Chopra, speaks from the South Court Auditorium on the ...

The director of the Consumer Financial Protection Bureau, Rohit Chopra, has been waiting for a phone call, letter, email, text — anything, really — from the Trump administration to say if he ...

Chinese luxury shopping is expected to remain subdued as its housing crisis and poor stock market performance drag on consumer confidence. Even at Richemont, greater China sales were down 18 per ...

After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to move forward with its ambition to convert its erectile dysfunction ...